Feature|Articles|February 15, 2024
- Pharmaceutical Executive: February 2024
- Volume 44
- Issue 1
Pharmaceutical Executive: February 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
Central to the Missionover 2 years ago
Two Frameworks for Orphan Drug IDN Launch Planningover 2 years ago
Sustainability and Progress Continue to Make Headlines in 2024over 2 years ago
Building Resiliency: Essential Leadership Principles for 2024Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5